A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: Doxil and Vinorelbine
Sponsor: Hematology Oncology Consultants
Collaborators: Ortho Biotech, Inc.